Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-α induction in monocytes by direct interaction with IκB kinases

Journal of Immunology

Volumn 174, Issue 1, 2005, Pages 498-506

  Syrovets, Tatiana ^a   Büchele, Berthold ^a   Krauss, Christine ^a   Laumonnier, Yves ^a   Simmet, Thomas ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL 11 OXO BETA BOSWELLIC ACID; ACETYL ALPHA BOSWELLIC ACID; BOSWELLIC ACID; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; DOWN REGULATION; ENZYME DEGRADATION; ENZYME REGULATION; IMMUNOPRECIPITATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REPORTER GENE;

EID: 10844262511     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.1.498     Document Type: Article

References (58)

1. Tak, P. P., and G. S. Firestein. 2001. NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 107:7.
2. Baldwin, A. S., Jr. 2001. Series introduction: the transcription factor NF-κB and human disease. J. Clin. Invest. 107:3.
3. Makarov, S. S. 2000. NF-κB as a therapeutic target in chronic inflammation: recent advances. Mol. Med. Today 6:441.
4. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109:S81.
5. Romas, E., M. T. Gillespie, and T. J. Martin. 2002. Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis. Bone 30:340.
6. Feldmann, M., and R. N. Maini. 2003. Lasker Clinical Medical Research Award: TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med. 9:1245.
7. Estrov, Z., S. Shishodia, S. Faderl, D. Harris, Q. Van, H. M. Kantarjian, M. Talpaz, and B. B. Aggarwal. 2003. Resveratrol blocks interleukin-1β- induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 102:987.
8. Shishodia, S., S. Majumdar, S. Banerjee, and B. B. Aggarwal. 2003. Ursolic acid inhibits nuclear factor-κB activation induced by carcinogenic agents through suppression of IκBα kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 63:4375.
9. Takada, Y., and B. B. Aggarwal. 2003. Betulinic acid suppresses carcinogen-induced NF-κB activation through inhibition of IκBα kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J. Immunol. 171:3278.
10. Ammon, H. P. T. 2002. Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases. Wien. Med. Wochenschr. 152:373.
11. Gupta, I., A. Parihar, P. Malhotra, G. B. Singh, R. Ludtke, H. Safayhi, and H. P. T. Ammon. 1997. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur. J. Med. Res. 2:37.
12. Gupta, I., A. Parihar, P. Malhotra, S. Gupta, R. Ludtke, H. Safayhi, and H. P. T. Ammon. 2001. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med. 67:391.
13. Gerhardt, H., F. Seifert, P. Buvari, H. Vogelsang, and R. Repges. 2001. Therapy of active Crohn disease with Boswellia serrata extract H 15. Z. Gastroenterol. 39:11.
14. Belsner, K., B. Büchele, U. Werz, T. Syrovets, and T. Simmet. 2003. Structural analysis of pentacyclic triterpenes from the gum resin of Boswellia serrata by NMR spectroscopy. Magn. Reson. Chem. 41:115.
15. Büchele, B., W. Zugmaier, and T. Simmet. 2003. Analysis of pentacyclic triterpenic acids from frankincense gum resins and related phytopharmaceuticals by high-performance liquid chromatography: identification of lupeolic acid, a novel pentacyclic triterpene. J. Chromatogr. B 791:21.
16. Safayhi, H., E. R. Sailer, and H. P. T. Ammon. 1995. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-β-boswellic acid. Mol. Pharmacol. 47:1212.
17. Takada, Y., and B. B. Aggarwal. 2004. Flavopiridol inhibits NF-κB activation induced by various carcinogens and inflammatory agents through inhibition of IκBα kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9. J. Biol. Chem. 279:4750.
18. Büchele, B., and T. Simmet. 2003. Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chromatography and photodiode array detection. J. Chromatogr. B 795:355.
19. Colognato, R., J. R. Slupsky, M. Jendrach, L. Burysek, T. Syrovets, and T. Simmet. 2003. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. Blood 102:2645.
20. Syrovets, T., B. Tippler, M. Rieks, and T. Simmet. 1997. Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathway. Blood 89:4574.
21. Syrovets, T., M. Jendrach, A. Rohwedder, A. Schüle, and T. Simmet. 2001. Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKKβ-mediated NF-κB activation. Blood 97:3941.
22. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55.
23. Syrovets, T., A. Schule, M. Jendrach, B. üichele, and T. Simmet. 2002. Ciglitazone inhibits plasmin-induced proinflammatory monocyte activation via modulation of p38 MAP kinase activity. Thromb. Haemost. 88:274.
24. Grandvaux, N., M. J. Servant, B. tenOever, G. C. Sen, S. Balachandran, G. N. Barber, R. Lin, and J. Hiscott. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76:5532.
25. Burysek, L., T. Syrovets, and T. Simmet. 2002. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and Janus kinase (JAK)/STAT signaling pathways. J. Biol. Chem. 277:33509.
26. Syrovets, T., B. Büchele, E. Gedig, J. R. Slupsky, and T. Simmet. 2000. Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIα. Mol. Pharmacol. 58:71.
27. Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31:3406.
28. Bey, E. A., and M. K. Cathcart. 2002. Antisense oligodeoxyribonucleotides: a better way to inhibit monocyte superoxide anion production? Methods Enzymol. 353:421.
29. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
30. Greaves, D. R., and K. M. Channon. 2002. Inflammation and immune responses in atherosclerosis. Trends Immunol. 23:535.
31. Watanabe, N., K. Nakada, and Y. Kobayashi. 1998. Processing and release of tumor necrosis factor α. Eur. J. Biochem. 253:576.
32. Udalova, I. A., J. C. Knight, V. Vidal, S. A. Nedospasov, and D. Kwiatkowski. 1998. Complex NF-κB; interactions at the distal tumor necrosis factor promoter region in human monocytes. J. Biol. Chem. 273:21178.
33. Yang, F., E. Tang, K. Guan, and C. Y. Wang. 2003, IKKβ plays an essential role in the phosphorylation. of RelA/p65 on serine 536 induced by lipopolysaccharide. J. Immunol. 170:5630.
34. Sizemore, N., N. Lerner, N. Dombrowski, H. Saturai, and G. R. Stark. 2002. Distinct roles of the IκB kinase α and β subunits in liberating nuclear factor κB (NF-κB) from IκB and in phosphorylating the p65 subunit of NF-κB. J. Biol. Chem. 277:3863.
35. Sakurai, H., H. Chiba, H. Miyoshi, T. Sugita, and W. Toriumi. 1999. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274:30353.
36. O'Connell, M. A., B. L. Bennett, F. Mercurio, A. M. Manning, and N. Mackman. 1998. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J. Biol. Chem. 273:30410.
37. Sanlioglu, S., C. M. Williams, L. Samavati, N. S. Butler, G. Wang, P. B. McCray, Jr., T. C. Ritchie, G. W. Hunninghake, E. Zandi, and J. F. Engelhardt. 2001. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-α secretion through IKK regulation of NF-κB. J. Biol. Chem. 276:30188.
38. Hawiger, J., R. A. Veach, X. Y. Liu, S. Timmons, and D. W. Ballard. 1999. IκB kinase complex is an intracellular target for endotoxic lipopolysaccharide in human monocytic cells. Blood 94:1711.
39. Gupta, I., V. Gupta, A. Parihar, S. Gupta, R. Ludtke, H. Safayhi, and H. P. T. Ammon. 1998. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur. J. Med. Res. 3:511.
40. Safayhi, H., T. Mack, J. Sabieraj, M. I. Anazodo, L. R. Subramanian, and H. P. T. Ammon. 1992. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J. Pharmacol. Exp. Ther. 261:1143.
41. McMillan, R. M. 2001. Leukotrienes in respiratory disease. Paediatr. Respir. Rev. 2:238.
42. Yamamoto, Y., and R. B. Gaynor. 2001. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107:135.
43. Beutler, B., K. Hoebe, X. Du, and R. J. Ulevitch. 2003. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J. Leukocyte Biol. 74:479.
44. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16:3.
45. Zhang, F. X., C. J. Kirschning, R. Mancinelli, X. P. Xu, Y. Jin, E. Faure, A. Mantovani, M. Rothe, M. Muzio, and M. Arditi. 1999. Bacterial lipopolysaccharide activates nuclear factor-κB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274:7611.
46. Imler, J. L., and L. Zheng. 2004. Biology of Toll receptors: lessons from insects and mammals. J. Leukocyte Biol. 75:18.
47. Toshchakov, V., B. W. Jones, P. Y. Perera, K. Thomas, M. J. Cody, S. Zhang, B. R. Williams, J. Major, T. A. Hamilton, M. J. Fenton, and S. N. Vogel. 2002. TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β- dependent gene expression in macrophages. Nat. Immunol. 3:392.
48. Fitzgerald, K. A., D. C. Rowe, B. J. Barnes, D. R. Caffrey, A. Visintin, E. Latz, B. Monks, P. M. Pitha, and D. T. Golenbock. 2003. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the Toll adapters TRAM and TRIF. J. Exp. Med. 198:1043.
49. Li, X., P. E. Massa, A. Hanidu, G. W. Peet, P. Aro, A. Savitt, S. Mische, J. Li, and K. B. Marcu. 2002. IKKα, IKKβ, and NEMO/IKKγ are each required for the NF-κB-mediated inflammatory response program. J. Biol. Chem. 277:45129.
50. Andreakos, E., S. M. Sacre, C. Smith, A. Lundberg, S. Kiriakidis, T. Stonehouse, C. Monaco, M. Feldmann, and B. M. Foxwell. 2004. Distinct pathways of LPS-induced NF-κB activation and cytokine production in human myeloid and non-myeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 103:2229.
51. Bharti, A. C., N. Donato, S. Singh, and B. B. Aggarwal. 2003. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101:1053.
52. Sakurai, H., S. Suzuki, N. Kawasaki, H. Nakano, T. Okazaki, A. Chino, T. Doi, and I. Saiki. 2003. Tumor necrosis factor-α-induced IKK phosphorylation of NF-κB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 278:36916.
53. Vermeulen, L., G. De Wilde, S. Notebaert, W. Vanden Berghe, and G. Haegeman. 2002. Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit. Biochem. Pharmacol. 64:963.
54. Li, Q., D. Van Antwerp, F. Mercurio, K. F. Lee, and I. M. Verma. 1999. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284:321.
55. Chen, L. W., L. Egan, Z. W. Li, F. R. Greten, M. F. Kagnoff, and M. Karin. 2003. The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9:575.
56. Takeda, K., O. Takeuchi, T. Tsujimura, S. Itami, O. Adachi, T. Kawai, H. Sanjo, K. Yoshikawa, N. Terada, and S. Akira. 1999. Limb and skin abnormalities in mice lacking IKKα. Science 284:313.
57. Tawab, M. A., A. Kaunzinger, U. Bahr, M. Karas, M. Wurglics, and M. Schubert-Zsilavecz. 2001. Development of a high-performance liquid chromatographic method for the determination of 11-keto-β-boswellic acid in human plasma. J. Chromatogr. B Biomed. Sci. Appl. 761:221.
58. Sterk, V., B. Büchele, and T. Simmet. Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta Med. In press.